IT WAS JUST AN ACCIDENT – Opens Friday, December 12th!
Director: Jafar Pahani
Upon the introduction of the normal RAR ligand, all-trans-retinoic acid, the chimeric receptor undergoes nuclear translocation. 3. Results: Translocation Tracking
The chimera is constructed by fusing the ligand-binding domain of the retinoic acid receptor (RAR) to a reporter sequence that allows tracking (e.g., green fluorescent protein). Hem#265 rar
This paper highlights a novel method that combines the ligand-binding domain (LBD) of RAR with the trafficking machinery of the GR, creating a chimeric receptor that moves from the cytoplasm to the nucleus upon ligand binding. 2. Methodology: Design of the GR-RAR Chimera Upon the introduction of the normal RAR ligand,
The development of a chimeric receptor that utilizes GR-like translocation properties while retaining RAR ligand specificity provides a robust, visual assay for ligand-receptor interactions. This methodology represents a significant step forward in in vivo monitoring of nuclear receptor signaling. To further refine this paper, please tell me: This paper highlights a novel method that combines
The translocation from cytoplasm to nucleus is observable in living cells, allowing for kinetic studies.
The Retinoic Acid Receptor (RAR) plays a crucial role in mediating the effects of all-trans-retinoic acid, which regulates cellular differentiation and development. Monitoring the activation of RAR, however, is challenging due to complex subcellular trafficking mechanisms. While retinoic acid receptor alpha (RAR-α) gene expression is associated with significant physiological processes, including cardiac function and zeaxanthin recovery, a direct, real-time monitor of receptor movement is needed.
The chimeric receptor provides a dramatic and easily monitored visual indicator of RAR ligand presence in the cellular environment.